Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies

E I Ette1, C A Howie, A W Kelman

  • 1FDA, Center for Drug Evaluation and Research, Rockville, Maryland 20857, USA.

Pharmaceutical Research
|May 1, 1995
PubMed
Summary

Monte Carlo simulations show that preclinical population pharmacokinetic parameter estimation is efficient for clearance and volume, but imprecise for interanimal variability. Optimal sampling times are not critical for overall parameter estimation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SU-E-I-23: Effective Estimation of Focal Spot Isocenter for Sinograms Obtained with Flying Focal Spot Scans for Filtered Back Projection.

Medical physics·2017
Same author

Some clinical implications of the protein binding of digoxin.

British journal of clinical pharmacology·2012
Same author

Cochlear nucleus neurons redistribute synaptic AMPA and glycine receptors in response to monaural conductive hearing loss.

Neuroscience·2009
Same author

Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction.

Gastroenterology·2002
Same author

Designing population pharmacokinetic studies: performance of mixed designs.

European journal of drug metabolism and pharmacokinetics·2001
Same author

Health surveillance of Glasgow medical undergraduates pursuing elective studies abroad (1992-1998).

Journal of travel medicine·2001

Area of Science:

  • Pharmacokinetics
  • Preclinical drug development
  • Computational modeling

Background:

  • Population pharmacokinetics (PopPK) is crucial for preclinical drug development.
  • Designing efficient preclinical studies with fixed sample sizes presents challenges.
  • Destructive sampling studies require careful planning to maximize data utility.

Purpose of the Study:

  • To evaluate the impact of sampling time arrangements on population pharmacokinetic parameter estimation efficiency in preclinical settings.
  • To assess the performance of three- and four-time point sampling designs using Monte Carlo simulations.
  • To provide insights for optimizing the design of destructive preclinical PopPK studies.

Main Methods:

  • Monte Carlo simulation technique applied to a one-compartment model with intravenous bolus input.

Related Experiment Videos

  • Evaluation of parameter estimation efficiency using percent prediction error, confidence interval coverage, and correlation analysis.
  • Inclusion of both inter- and residual intra-animal variability in simulated datasets.

    • Main Results:

    • Typical population parameter estimates for clearance and volume were accurately and precisely estimated.
    • Interanimal variability was inaccurately and imprecisely estimated across most sampling schedules.
    • The precise location of the third and fourth time points had minimal impact on overall parameter estimation efficiency, though some parameters were sensitive.

    Conclusions:

    • Three- and four-time point sampling designs can efficiently estimate key population pharmacokinetic parameters like clearance and volume in preclinical studies.
    • Estimating interanimal variability requires more optimized sampling strategies than those evaluated.
    • Study design flexibility exists regarding the exact timing of later sample collection points, but careful consideration is needed for specific parameter sensitivity.